Recent progress in adjuvant discovery for peptide-based subunit vaccines
about
Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protectionNative cellulose nanofibrills induce immune tolerance in vitro by acting on dendritic cellsA consensus-hemagglutinin-based vaccine delivered by an attenuated Salmonella mutant protects chickens against heterologous H7N1 influenza virus.Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.Recombinant TgHSP70 Immunization Protects against Toxoplasma gondii Brain Cyst Formation by Enhancing Inducible Nitric Oxide Expression.Peptide amphiphile micelles self-adjuvant group A streptococcal vaccinationMeta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondiiComparison of Fluorinated and Nonfluorinated Lipids in Self-Adjuvanting Delivery Systems for Peptide-Based Vaccines.Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's ToolboxA Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?Immune Response to Coccidioidomycosis and the Development of a Vaccine.Recent advances in peptide-based subunit nanovaccines.Recent advances in vaccine delivery.Reverse Vaccinology: The Pathway from Genomes and Epitope Predictions to Tailored Recombinant Vaccines.Peptide-based synthetic vaccines.Lipopeptide Nanoparticles: Development of Vaccines against Hookworm Parasite.Intranasal delivery of nanoparticle-based vaccines.Systematic evaluation of self-adjuvanting lipopeptide nano-vaccine platforms for the induction of potent CD8(+) T-cell responses.Synthetic melanin bound to subunit vaccine antigens significantly enhances CD8+ T-cell responses.Inulin: A New Adjuvant With Unknown Mode of Action.Investigations into the efficacy of multi-component cocaine vaccines.Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.Fundamentals and Methods for T- and B-Cell Epitope Prediction.Linear and branched polyacrylates as a delivery platform for peptide-based vaccines.Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus.Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccines.Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer.Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants.
P2860
Q27304818-B883F909-7D70-4C17-93C9-4810B4B36929Q27317032-D2360356-6F8F-41B6-BD0F-E2A82085D8A7Q30148715-33FE1F16-7FDB-49A8-9FA1-FA245A8FDFF3Q30398876-C48C8084-5CC2-4B9E-8B35-C5F4A8DB1F88Q33599823-C59654E2-360A-481D-9359-051F29A02A8EQ35192883-E819826E-D87A-4175-A824-A5D2EA7B40A8Q36009558-83D62451-A7FB-46B6-AA6F-A75697C1BFC7Q36240866-4E7722E1-6233-4E0C-A139-CE5E0D593F97Q36280591-F29653AF-53A9-4039-B773-62DA882227CFQ36907013-1FB346E1-8A0F-463E-8B22-53E21C2775ACQ37061084-91919306-0EC4-4423-8D76-C0673F23D1E9Q37690431-1DAC58E4-E2FB-4B23-B6B2-3CA7BE1BE58FQ37731260-589F3C7F-9085-4E7C-9C3C-FEA68039488BQ38296076-14B408DB-B12B-46F7-BBE5-F366098044AFQ38669255-E0C4EA19-AB65-449B-9FF9-7BD120BE15E7Q38807834-8346449E-0C25-48FE-88D7-94EA0E0E5952Q38914295-1D9F5443-4AD4-4F1F-9B8D-634B08EABA0BQ39013387-C7D23703-AAAD-4D4B-B35F-1DAAF3DF70CBQ39113247-C4C546DA-5CAB-4852-874F-EBBC51B3E3ABQ40876858-842E96ED-9441-4670-ADAF-08092E3C0CEEQ41035371-4F7410C0-06E3-411E-94DF-D08885E05B01Q42330773-7744BF5F-79FB-42B6-9130-61E7414FB4ADQ47216341-9D6979E9-6B69-4939-ADE2-2DC8063E6B10Q48116102-9D9632DB-C8A5-4EA8-A32B-101D8410ABD1Q49594989-F6DE7C00-9ABE-4362-B05B-C6022251C554Q51539386-F13A6DF8-76E6-4155-8C8F-D6EE14E15E14Q53086117-B8C50942-6399-49FF-A5FC-E3797AB9EEF0Q55333118-9CB53172-DB6A-4375-8F4A-57FCC74E0B73Q55399222-71ED7410-72FD-4B7B-B175-953AFD29DA4BQ55472927-F9C55435-BA4A-4848-B020-CE890299D317Q55517783-ED51F0FF-E3C3-4167-AF58-B72CA283352F
P2860
Recent progress in adjuvant discovery for peptide-based subunit vaccines
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@ast
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@en
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@nl
type
label
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@ast
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@en
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@nl
prefLabel
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@ast
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@en
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@nl
P2860
P50
P356
P1476
Recent progress in adjuvant discovery for peptide-based subunit vaccines
@en
P2093
Fazren Azmi
P2860
P304
P356
10.4161/HV.27332
P577
2013-12-03T00:00:00Z